Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
QuickStats: Percentage of Persons With Current Asthma* Who Used
Inhaled Medication During the Preceding 3 Months, by Medication Type
and Symptom Severity Level† --- United States, 2003
* Persons with current asthma were respondents who reported ever being told by a medical professional that they had asthma and who still had asthma.
† The frequency of symptoms and degree of activity limitation were used to classify those with current asthma into four symptom severity groups. Levels are
defined by the National Asthma Education and Prevention Program in
Guidelines for the Diagnosis and Management of Asthma
(available at
http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm).
In 2003, approximately two thirds of persons with current
asthma used one or more inhaled medications during
the preceding 3 months, and the proportion using inhaled medications increased
with levels of symptom severity. Approximately half of all respondents with asthma used a
B2A-S rescue inhaler, one third used an inhaled corticosteroid,
and one fifth used a B2A-L inhaler. Each symptom severity
level had a similar pattern of inhaled medication use.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
